| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |